Astrana Health, Inc.
ASTH · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1,394 | $1,224 | $1,503 | $1,511 |
| - Cash | $462 | $340 | $259 | $288 |
| + Debt | $1,087 | $448 | $451 | $472 |
| Enterprise Value | $2,019 | $1,332 | $1,696 | $1,695 |
| Revenue | $956 | $655 | $620 | $665 |
| % Growth | 46% | 5.5% | -6.7% | – |
| Gross Profit | $82 | $78 | $71 | $63 |
| % Margin | 8.5% | 11.9% | 11.5% | 9.5% |
| EBITDA | $39 | $31 | $24 | $14 |
| % Margin | 4.1% | 4.8% | 3.8% | 2.1% |
| Net Income | $0 | $9 | $7 | -$7 |
| % Margin | 0% | 1.4% | 1.1% | -1% |
| EPS Diluted | -0.33 | 0.19 | 0.14 | -0.14 |
| % Growth | -273.7% | 35.7% | 200% | – |
| Operating Cash Flow | $10 | $91 | $17 | -$11 |
| Capital Expenditures | -$3 | -$1 | -$3 | -$3 |
| Free Cash Flow | $7 | $89 | $14 | -$13 |